Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neuroma, Acoustic 1Neurofibromatosis 2 1Meningioma 1Lung Neoplasms 1Ependymoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 127Carboplatin 125Pemetrexed 105Cisplatin 79Paclitaxel 58osimertinib 55Nivolumab 52Docetaxel 52durvalumab 48Specimen Handling 40Magnetic Resonance Spectroscopy 36Gemcitabine 35Radiosurgery 29atezolizumab 27Cetuximab 26130-nm albumin-bound paclitaxel 26Radiotherapy 22Ipilimumab 21Drug Therapy 21cemiplimab 20Bevacizumab 20amivantamab 18Taxes 16Ramucirumab 13tislelizumab 12alectinib 12Biopsy 12lazertinib 11Radiation 11Oxaliplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × brigatinib × 90 days × Clear all
NCT05100069 2026-03-17

Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

Takeda

Recruiting
500 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡